Aug 30 (Reuters) - U.S. FDA:

* TELIGENT PHARMA, INC.’S ISSUES VOLUNTARY RECALL OF LIDOCAINE HCL TOPICAL SOLUTION 4% (LOT # 14218, EXP. 09/2022) DUE TO SUPER POTENCY

* FDA SAYS TO DATE, TELIGENT PHARMA, HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS RELATED TO RECALL

((Reuters.Briefs@thomsonreuters.com;))